Liver transplantation.

Crit Care Clin

Department of Surgery, University of Minnesota Hospital and Clinic, Minneapolis.

Published: October 1990

Organ transplantation offers increased survival and improved quality of life to many patients with end-stage liver disease. Major advances in this field have included better organ acquisition and preservation as well as improved intraoperative techniques and management. An additional major factor in improved survival of transplant recipients is the elevated level of care available in intensive care units. Diligent postoperative care has led to early recognition and appropriate treatment of complications that previously were fatal. The intensive care unit team, in tandem with the transplant surgical service, significantly contributes to the successful outcome of the liver transplant recipient.

Download full-text PDF

Source

Publication Analysis

Top Keywords

intensive care
8
liver transplantation
4
transplantation organ
4
organ transplantation
4
transplantation offers
4
offers increased
4
increased survival
4
survival improved
4
improved quality
4
quality life
4

Similar Publications

Background: Chronic obstructive pulmonary disease (COPD) affects breathing, speech production, and coughing. We evaluated a machine learning analysis of speech for classifying the disease severity of COPD.

Methods: In this single centre study, non-consecutive COPD patients were prospectively recruited for comparing their speech characteristics during and after an acute COPD exacerbation.

View Article and Find Full Text PDF

Purpose: The C-reactive protein (CRP)-albumin-lymphocyte (CALLY) index is a newly developed biomarker that combines measurements of CRP, serum albumin, and lymphocyte count. This index provides a thorough assessment of a patient's inflammation level, nutritional condition, and immunological function. The objective of this study is to examine the correlation between the CALLY index and all-cause mortality in COPD patients.

View Article and Find Full Text PDF

Roads to remission: evolving treatment concepts in type 2 inflammatory diseases.

EClinicalMedicine

February 2025

Institute of Laboratory Medicine and Pathobiochemistry, Molecular Diagnostics, Philipps University Marburg, Marburg, Germany.

Unlabelled: Non-communicable diseases (NCDs) characterised by type 2 inflammation, including asthma, allergic rhinitis, chronic rhinosinusitis with nasal polyps, atopic dermatitis, food allergies and eosinophilic esophagitis, are increasing in prevalence worldwide. Currently, there is a major paradigm shift in the management of these diseases, towards the concept of disease modification and the treatment goal remission, regardless of severity and age. Remission as a treatment goal in chronic inflammatory NCDs was first introduced in rheumatoid arthritis, and then adopted in other non-type 2 inflammatory diseases.

View Article and Find Full Text PDF

Primary malignant melanoma of the lung; a case report and literature review.

Respir Med Case Rep

December 2024

Division of Pulmonary Disease and Critical Care Medicine, University of Kentucky College of Medicine, Bowling Green, KY, USA.

Primary pulmonary malignant melanoma is an extremely rare non-epithelial malignancy. Literature is merely limited to a few anecdotal case reports. Herein we present a case of a 74-year-old female who was diagnosed with primary malignant melanoma of the lung.

View Article and Find Full Text PDF

Background: Critical care medicine (CCM) faces challenges in attracting new physicians due to its demanding nature. Understanding medical students' and interns' perceptions of CCM is essential to address physician shortages and improve medical training.

Objective: To evaluate the factors influencing specialty selection and explore perceptions of final-year medical students and interns toward CCM at Jazan University.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!